Precision medicine firm eyes US expansion

iCarbon X's technology is likely to be first applied to the beauty industry MA SI

A big-data startup focusing on precision medicine, set up by former CEO of China's genome sequencing giant Beijing Genomics Institute, is planning to expand to the United States after Tencent Holdings Ltd led a nearly 1 billion yuan ($150 million) investment in the seven-month old company.

WangJun, CEO and co-founder of iCarbonX, said on Tuesday: "We will make strategic moves in the US and Europe this year, through either investments or acquisitions."